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Abstract  
Candida albicans is a commensal organism that can be isolated from the majority of healthy 
individuals. However, in certain susceptible individuals C.albicans can become pathogenic leading 
to the mucocutaneous infection; oral candidiasis. Murine models and in vitro monolayer cultures 
have generated some data on the likely virulence and host factors that contribute to oral candidiasis 
but these models have limitations. Recently, tissue engineered oral mucosal models have been 
developed to mimic the normal oral mucosa but little information is available on their true 
representation. In this study we assessed the histological features of three different tissue engineered 
oral mucosal models compared to the normal oral mucosa and analysed both cell damage and 
cytokine release following infection with C.albicans.  Models comprised of normal oral 
keratinocytes and a fibroblast-containing matrix displayed more similar immunohistological and 
proliferation characteristics to normal mucosa compared to models composed of an oral carcinoma 
cell line. Although all models were invaded and damaged by C.albicabs in a similar manner, the 
cytokine response was much more pronounced in models containing normal keratinocytes. These 
data suggest that models based on normal keratinocytes atop a fibroblast-containing connective 
tissue will significantly aid in dissecting the molecular pathogenesis of oral candidiasis. 
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1. Introduction 
Candida albicans is a fungal organism that forms part of the normal oral microbial flora in 
approximately 50% of healthy individuals [1]. C. albicans is a polymorphic organism and can grow 
as yeast, pseudohyphae or hyphae; each differing in its morphology and virulence [2]. The yeast 
form is commonly associated with the commensal carrier state where a balance exists between the 
oral microbial flora and the host innate immune response. If this balance is disrupted, for example 
in those with HIV infection or in immunosuppressed individuals, those receiving immunotherapy, 
corticosteroid or prolonged antibiotic therapy, or in individuals with uncontrolled diabetes, salivary 
gland dysfunction (Sjögren’s syndrome) or wearing dentures, C. albicans may proliferate and 
convert to its hyphal form which penetrates into the oral mucosa causing the tissue damage that is 
frequently observed in oral candidiasis [3,4]. 
 
Several experimental approaches have been used in an attempt to identify the key molecules 
involved in the interaction of C. albicans with oral epithelial cells. Immunohistological analysis of 
biopsies from patients with oral candidiasis have been performed [5-7] but such studies are not 
amenable to experimental manipulation and so can only provide limited information. Murine 
models of oral candidiasis have identified several potential virulence factors that may play a role in 
pathogenesis [8-10], but since C. albicans does not naturally colonise the murine oral cavity [11] it 
is not clear how representative these studies are. Moreover, there are significant differences 
between the innate immune systems of humans and mice [12] which may make the results of 
murine studies difficult to interpret. To address these concerns numerous in vitro C. albicans 
infection studies have used monolayer cultures of human oral keratinocytes or oral epithelial cell 
lines [13-16]. However, the oral mucosa is a complex multi-layered, multi-cellular tissue consisting 
of increasingly differentiated epithelial cells and so monolayer cultures are unlikely to be 
representative. Recently, multi-layered organotypic three-dimensional in vitro culture systems have 
been developed to mimic the oral mucosa [17-20]. The reconstituted human oral epithelial (RHOE) 
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model, which is based upon the TR146 buccal carcinoma cell line cultured on a porous 
polycarbonate insert, has been widely used in C. albicans infection studies [21-25]. More advanced, 
alternative tissue engineered mucosal models have since been developed that consist of oral 
keratinocytes cultured on a fibroblast-containing extracellular matrix [20,26,27]. To date no study 
has examined whether these models display histological features or express immune molecules 
similarly to the oral mucosa. In this study we compared three tissue engineered oral mucosal models 
with normal healthy oral mucosa for expression of key oral mucosal markers using 
immunohistochemistry. We also compared these models in terms of invasion, cell damage, cytokine 
and innate immune molecule production in response to C. albicans infection in order to identify 
which model most accurately represents an in vitro experimental model of oral candidiasis.  
 
2. Results 
2.1 Oral mucosal models differ in histology and expression of differentiation markers 
Sections of paraffin-embedded RHOE, EpiOral™ or Full-thickness oral mucosa (FTOM) were 
compared with normal oral buccal mucosa for histological similarities.  Hematoxylin and eosin 
staining showed that all three mucosal models have a similar thickness of 10-15 cell layers which is 
much less than normal buccal mucosa (Fig. 1A). Like the normal oral mucosa, both FTOM and 
EpiOral™ models displayed a fibroblast-containing connective tissue topped by basal cells followed 
by maturing spinous epithelium that parakeratinizes towards the apical surface. Noticeably absent 
from both the FTOM and EpiOral™ models but present in the normal mucosa are rete pegs, which 
are characteristic of papillary ridges, a vascular component and immune cells. In contrast to these 
models, the RHOE model is devoid of a fibroblast and connective tissue component and displays 
minimal differentiation and parakeratinization of the upper layers of the epithelium (Fig. 1A).  
 
Immunohistochemical staining using the pan-cytokeratin markers MNF116 and AE1&AE3 showed 
that all the mucosal models consisted entirely of epithelium without contaminating cells (data not 
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shown).  Staining for cytokeratin 13, a specific marker for cell differentiation, showed that the 
FTOM and EpiOral™ models contain well-differentiated cytokeratin 13-positive cells in the upper 
layers of the mucosa whilst the basal and supra-basal cells were negative; and this was comparable 
to the normal oral mucosa (Fig. 1B). In contrast, the RHOE model was cytokeratin 13-negative 
confirming that this model does not contain differentiated epithelium (Fig. 1B).  Collagen IV 
staining was used to assess the presence of a basement membrane between the epithelium and the 
connective tissue as this plays a key role in anchoring the epithelium to the lamina propria. Similar 
to the normal oral mucosa, the FTOM model displayed a continuous basement membrane that 
separated the oral basal cells from the lamina propria. In the former, collagen IV staining of blood 
vessels was also observed (Fig. 1C). In marked contrast to the FTOM, both the EpiOral™ and 
RHOE did not display collagen IV staining (Fig. 1C).  
 
The proliferation of basal cells that differentiate as they reach the apical surface is an important 
aspect of the developing oral mucosa. Ki67 staining was used to identify the location of actively 
proliferating cells. Both FTOM and EpiOral™ models displayed Ki67-positive cells that were 
restricted to the basal layers analogous to the normal oral mucosa (Fig. 1D). Although the RHOE 
models did display some Ki67-positve cells in the basal layers, many positive cells were also seen 
throughout the upper layers of the mucosal model (Fig. 1D).  To confirm the immunohistochemical 
observations, the proliferation index of all three models along with the oral mucosa was also 
assessed. The FTOM and EpiOral™ models had a similar proliferation index that was not 
significantly different to that of the normal mucosa. However, the RHOE had a significantly 
(p<0.01) lower proliferation index to the FTOM, EpiOral™ and normal mucosa (Fig. 2). 
 
2.2 C. albicans infection of oral mucosal models – histological examination 
Mucosal models were infected with 5x106CFU of a C. albicans wild-type strain (CAF2-1) for 24 h 
and, along with tissue obtained from a patient with oral candidiasis, were examined histologically. 
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C. albicans hyphae are clearly observed penetrating the upper epithelial layers of the oral mucosa in 
oral candidiasis. The epithelium also appears mildly dysplastic and the upper layers show signs of 
desquamation (Fig. 3A). In all three oral models, C. albicans formed a biofilm on top of the 
epithelium consisting of both yeast and hyphae. The biofilm on the RHOE was consistently not as 
compact as those formed on the FTOM and EpiOral™ models. Similar to the situation in oral 
candidiasis, hyphal penetration into the upper layers of the epithelium along with epithelial 
desquamation was observed in all three oral models, although this was less evident in the RHOE 
mucosa (Fig. 3B-D). All three models also displayed loss of intraepithelial attachments indicative of 
tissue damage which was confirmed by a time-dependent increase in lactate dehydrogenase (LDH) 
release over 24 h signifying a gradual loss of cell viability following infection (Fig. 4A). 
 
2.3 Oral mucosal models differ in cytokine release upon infection with C. albicans 
Release of the inflammatory cytokines TNF-α, IL-1β and CXCL8 was analysed to determine 
whether the mucosal models responded differently to C. albicans infection.  All three uninfected 
models constitutively produced similar amounts of TNF-α, whereas uninfected FTOM and 
EpiOral™ models constitutively secreted significantly more IL-1β and CXCL8 (p<0.05) than the 
RHOE models (Fig 4B-C). Twenty-four hours following C. albicans infection, all three displayed at 
least a 5-fold increase in TNF-α secretion compared to uninfected controls. However, the FTOM 
model secreted significantly more TNF-α then the EpiOral™ and RHOE models (Fig. 4B; p<0.05). 
Infected FTOM and EpiOral™ models secreted significantly (p<0.05) more IL-1β and CXCL8 than 
uninfected controls and also produced 4-5 fold greater levels of both cytokines than those elicited by 
infected RHOE models. In fact, C. albicans-infection of RHOE models failed to stimulate an IL-1β 
response and the CXCL8 response was modest compared to that produced by the FTOM and 
EpiOral™ models. 
 
2.4 Differential expression of human β-defensin 2 (hBD2) by mucosal models 
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Expression of hBD2, which has been previously shown to be up-regulated in Candida-infected oral 
epithelium [28,29], was examined in the mucosal models. All three models displayed little or no 
staining for hBD2 in uninfected controls (Fig. 5). However, following infection with C. albicans, the 
expression of hBD2 was markedly increased in the FTOM and EpiOral™ models, particularly in the 
more differentiated, upper epithelial layers where intense immunostaining was observed.  In 
contrast, the expression of hBD2 in infected RHOE models was slight and focused in one or two 
small patches within the epithelium (Fig. 5). Furthermore, constitutive expression of hBD 1 and 3 
was observed throughout the epithelium in the normal healthy oral mucosa and in the FTOM and 
EpiOral™ models but was absent from the RHOE models (data not shown). 
 
 
3. Discussion 
One limiting factor preventing a better understanding of the interaction between C. albicans and the 
oral mucosa is the availability of a suitable in vitro model. Monolayer cultures of oral keratinocytes 
have been extensively used to examine the interaction of C. albicans with host cells [21-25], but 
such studies provide limited information because the oral mucosa is a multi-layered complex tissue 
and signalling between cells may be important in host defence. Recently, the increased use of the 
RHOE multi-layered in vitro mucosal model has enabled more complex studies to be performed. 
However, there is limited data on whether this model is representative of the normal oral mucosa. In 
this study we compared three in vitro models of the oral mucosa (FTOM, EpiOral™ and RHOE) for 
histology, differentiation and proliferation status, and cellular response to C. albicans infection to 
determine which would be most representative of the normal oral mucosa. Both the FTOM and 
EpiOral™ models are comprised of normal oral keratinocytes cultured on a fibroblast-containing 
matrix. Fibroblasts are essential for supplying factors that aid in the proliferation and differentiation 
of keratinocytes into mature squamous epithelia [30]. Therefore, it is not surprising that the FTOM 
and EpiOral™ models displayed similar differentiation and proliferation characteristics to that of 
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the normal oral mucosa. In contrast, the RHOE models, which are generated from a buccal 
carcinoma cell line (TR146) that was originally isolated from a neck metastasis [31], formed 
undifferentiated, non-para-keratinized stratified epithelium in which cell proliferation was not 
restricted to the basal layers. The altered phenotype of these cells due to genetic changes associated 
with tumor transformation and the lack of fibroblast support are the likely explanations for the lack 
of differentiation in this model. Interestingly, we found that when TR146 cells were cultured on a 
fibroblast-containing collagen support, differentiation was markedly enhanced (unpublished 
observations), underscoring the importance of a fibroblast-containing connective component in oral 
models. We found the main difference between the FTOM and EpiOral™ models is the presence of 
a collagen IV-containing basement membrane which may facilitate enhanced anchorage of the 
FTOM basal cells to the connective tissue compared to EpiOral™ models.    
 
To assess their usefulness at mimicking oral candidiasis, the mucosal models were infected with C. 
albicans and then analysed both histologically and for inflammatory cytokine release. Candida 
biofilm formation and hyphal penetration into the upper layers of the epithelium was observed for 
all three models replicating the situation in oral candidiasis.  Epithelial cell damage in all models 
included desquamation of the upper epithelial layers and marked cellular damage, which was 
associated with a time-dependent increase in LDH release. Such findings are consistent with clinical 
observations of mucosal Candidal infections [32] and previous studies using mucosal models [33]. 
We also observed breakdown of epithelial cellular junctions which was associated with loss of E-
cadherin expression in all three models as assessed by immunohistochemistry (unpublished 
observations), mirroring the observations made by Villar et al in their experiments using a mucosal 
model constructed of immortalised epithelial cells [34]. 
 
Although the histological and viability data were similar for all three models following C. albicans 
infection, the secretion of inflammatory cytokines was markedly different. Previous studies have 
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shown increased expression of numerous cytokines in response to C. albicans infection in vivo and 
in vitro and these are essential for directing an appropriate immune response (reviewed by [35]). 
FTOM and EpiOral™ models were more responsive to infection and secreted significantly more 
inflammatory cytokines than the RHOE models. In fact, the RHOE models displayed no increase in 
IL-1β production following infection while CXCL8 secretion was only slightly elevated. Moreover, 
unstimulated FTOM and EpiOral™ models constitutively secreted significantly more CXCL8 than 
the RHOE models. Such differences have been observed previously in monolayer cultures [36]. 
Major differences in anti-microbial peptide expression were also observed between the oral mucosal 
models. Specifically, the FTOM and EpiOral™ models constitutively expressed hBD 1 & 3 in a 
manner similar to normal oral mucosa [29], whereas the RHOE model lacked expression of these 
proteins. Furthermore, when infected with C. albicans, hBD2 was markedly up-regulated in the 
FTOM and EpiOral™ models in a similar manner to that described for the normal oral mucosa 
[28,29], whereas the RHOE model showed only very minor increases in expression. The disparities 
in the expression of these immune molecules between models are likely to be due to genetic 
differences between normal and tumor cells where gene expression of cytokines, pattern recognition 
receptors, anti-microbial peptides and cell signaling molecules are often dysregulated [37,38].  
 
Taken together, our data show that compared to RHOE models, the FTOM and EpiOral™ models 
are histologically much closer to and express the same pattern of innate immune molecules as 
normal oral mucosa. These data suggest that FTOM and EpiOral™ models represent a more 
advanced model of the oral mucosa that should significantly aid in dissecting the molecular 
mechanisms involved in the innate immune response against C. albicans. Currently, the main 
limitation of these models is that they currently do not include immune cells such as neutrophils, 
Langerhans cells or T lymphocytes that are important in the host response to Candida infections 
[39,40]. However, as with the RHOE models [25], the introduction of these immune cells into the 
mucosal models is possible and the likelihood of generating more complex tissue engineered oral 
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mucosal models containing several cell types is imminent.  
 
 
4. Materials and methods 
4.1 Isolation and culture of normal oral keratinocytes and fibroblasts 
Normal oral keratinocytes and oral fibroblasts were isolated from biopsies of normal buccal mucosa 
removed from healthy individuals with written, informed consent (ethical approval 09/H1308/66) as 
previously described [27]. To isolate keratinocytes, oral biopsies were incubated with 0.1% w/v 
Difco-Trypsin (Difco Laboratories, Detroit, MI) overnight at 4°C, followed by mechanical removal 
of the epidermal layer from the dermis. Keratinocytes were collected by centrifugation and cultured 
with a feeder layer of irradiated 3T3 murine fibroblasts in keratinocyte culture media (DMEM and 
Ham’s F12 medium in a 3:1 ratio, supplemented with 10% FBS, 10ng/ml epidermal growth factor 
(EGF), 0.4μg/ml hydrocortisone, 1.8x104 mol/l adenine, 5μg/ml insulin, 1.7ng/ml cholera toxin, 
2x10-7 M tri-iodothyronine, 0.625 μg/ml amphotericin B, 100 IU/ml penicillin and 100μg/ml 
streptomycin (all from Sigma, Poole, UK). Oral fibroblasts were isolated from the dermal tissue 
following overnight treatment with collagenase A (Sigma, Poole, UK) at 37°C in a 5% CO2 
humidified incubator. Fibroblasts were collected by centrifugation and cells cultured in DMEM 
supplemented with 10% FBS, 100 IU/ml penicillin and 100μg/ml streptomycin at 37°C, 5% CO2. 
 
4.2 Oral mucosal models 
RHOE models based upon TR146 cells were purchased from SkinEthic Laboratories (Nice, France) 
and maintained as described by the manufacturer’s instructions. EpiOral™ models based on 
primary buccal keratinocytes cultured on a fibroblast-containing collagen-based matrix were 
purchased from MatTek Corporation (Ashland, MA) and maintained as described by the 
manufacturer. Full-thickness oral mucosal (FTOM) models were generated as previously described 
[27]. Briefly, dermis was prepared from glycerol-preserved skin from human cadavers (Euroskin 
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Bank, Beverwijk, Netherlands). The skin was washed several times with PBS and decellularised by 
incubation with 1M NaCl overnight at 37°C. The epidermis was removed from the dermal layer, 
which was then washed extensively in PBS, cut into 10mm diameter circular pieces and placed 
basement membrane uppermost into a 10mm, 0.4μm pore polycarbonate snapwell tissue culture 
insert (Corning, New York, NY). Five x 105 fibroblasts (between passages 2-6) and 5x105 oral 
keratinocytes (between passages 2-4) were seeded onto the dermis in 200μl of keratinocyte 
medium. The lower compartment of the snapwell insert was filled with 2ml of keratinocyte medium 
and the composites incubated at 37°C in a 5% CO2 humidified incubator. Seventy-two hours later 
composites were taken to an air liquid interface by aspirating the medium from the centre of the 
dermis-containing insert. Mucosal models were maintained at 37°C for 14 days at an air liquid 
interface with fresh medium added every 2 days. 
  
4.3 Infection of mucosal models with C. albicans 
C. albicans (wild-type strain CAF2-1) was cultured in yeast-peptone-dextrose (YPD) medium 
overnight at 25°C. Yeast cells were pelleted by centrifugation, washed twice with PBS and 
resuspended in PBS at 5x107CFU/ml. FTOM, RHOE and EpiOral™ models were infected with 
100μl (5 x 106CFU) CAF2-1 for up to 24 h at 37°C at 5% CO2; PBS alone was added to the 
uninfected control. Prior to infection, 1.5 ml fresh keratinocyte medium was placed in the lower 
chamber of the snapwell. After 24 h the medium from the lower chamber was collected for further 
analysis and the models washed twice in PBS, fixed in 10% PBS-buffered formalin and then 
embedded in paraffin.  
 
4.4 Cytokine production and cell damage analysis 
Release of the cytokines TNF-α, IL-1β and CXCL8 was quantified by ELISA (OptiEIA, BD 
Biosciences, San Jose, CA) according to the manufacturer’s instructions. Cell damage caused by C. 
albicans was assessed by measuring release of cellular lactate dehydrogenase (LDH) into the culture 
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medium using the CytoTox96 enzyme assay kit (Promega, Madison, WI). 
  
4.5 Immunohistochemistry 
Immunohistochemistry was performed on formalin-fixed paraffin-embedded mucosal models and 
oral biopsies from patients with oral candidiasis (with written, informed consent and ethical 
approval 07/H1309/105). Tissue sections (4 µm) were de-waxed with xylene, rehydrated through a 
series of alcohols and immersed in 3% H2O2 in ethanol to quench endogenous peroxidase activity. 
Antigen retrieval was performed by microwaving for 8 min 10 mM citrate buffer (pH 6.0). Sections 
were blocked with normal rabbit serum for 30 min at room temperature and then incubated with 
primary antibody (Ki67, cytokeratin 13 (Dako, Copenhagen, Denmark), Collagen IV (Sigma, Poole, 
UK), human β defensin-2 (Peprotech, London, UK) for 60 min at room temperature, followed by 
incubation with biotinylated secondary antibody and streptavidin-HRP for 30 min at room 
temperature (Vectastain Elite ABC kit, Vector Laboratories, Peterborough, UK). Staining was 
visualised using 3,3’-diaminobenzidine chromagen substrate followed by counterstaining with 
haematoxylin. Sections were mounted and analysed by light microscopy. Control sections were 
prepared in the same manner but incubated with isotype-matched murine IgG antibody.  
Proliferation index was calculated as a percentage of Ki67-positive stained cells within the basal 
and supra-basal cell layers within five randomly selected fields of view (x40).  
 
4.6 Periodic Acid Schiff (PAS) staining of C. albicans-infected composites 
Tissue sections (4 µm) were cut, de-waxed with xylene, rehydrated through a series of alcohol 
solutions, treated with 1% periodic acid (BDH, Leicestershire, UK) for 5 min, washed with distilled 
water and then incubated in Schiff’s reagent (BDH, Leicestershire, UK) for 15 min. After washing 
under running tap water for 10 min, sections were counterstained with Mayer’s haematoxylin, 
passed through Scott’s tap water, de-hydrated, mounted and analysed by light microscopy. 
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4.7 Statistical analysis 
To determine significances between groups, comparisons were made using Mann-Whitney U or 
ANOVA using GraphPad Prism (San Diego, CA). For all statistical tests a p-value of at least <0.05 
was considered statistically significant. 
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Figure Legends  
Figure 1. Differences and similarities in differentiation, keratinization, basement membrane 
composition and proliferation of three oral mucosal models compared to normal oral mucosa. 
Hematoxylin and eosin stained sections (A). Sections stained by immunohistochemistry for 
cytokeratin 13 (B), collagen IV (C) and the proliferation marker ki67 (D). Each panel consists of (i) 
normal healthy oral mucosa, (ii) FTOM, (iii) EpiOral™ and (iv) RHOE. Images are representative 
of models from three individual experiments each performed in triplicate. Scale bar = 100µM. 
 
Figure 2. The proliferation index of FTOM and EpiOral™ mucosal models are similar to the 
normal oral mucosa. Sections of FTOM, EpiOral™ and the RHOE mucosal models and normal 
oral mucosa were stained for Ki67 and the number of Ki67-positive cells within the basal and 
supra-basal layers calculated as an overall percentage of proliferative cells. Data shown represent 
mean + SEM of three independent experiments each performed in triplicate with 5 randomly 
selected fields of view (x40) analysed per group. *p<0.01 determined by ANOVA compared to the 
RHOE model. 
 
Figure 3. Penetration of hyphal C. albicans into the epithelium of oral mucosal models is 
similar to oral candidiasis in vivo. Representative images of PAS stained sections from (A) oral 
candidiasis in vivo, (B) FTOM, (C) EpiOral™ and (D) RHOE show hyphal penetration into the 
upper layers of the epithelium in all three models which is analogous to oral candidiasis in vivo. All 
three models have a Candida biofilm and tissue damage due to loss of inter-epithelial contacts is 
observed. Images are representative of models from three individual experiments each performed in 
triplicate Scale bar = 100µM, except panel 3B where scale bar = 50µM.  
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Figure 4. C. albicans induces cell damage and differential cytokine release in oral mucosal 
models.  FTOM, EpiOral™ and RHOE mucosal models were infected with 5 x 106CFU C. albicans 
for up to 24 h and LDH and cytokine release (at 24 h) measured. (A) C. albicans caused a time-
dependent increase in cell damage as determined by LDH release in all three mucosal models. In 
vitro oral mucosal models elicited different levels of TNF-α (B), IL-1β (C) and CXCL8 (D) release 
upon C. albicans infection. Data are mean + SEM of three independent experiments each performed 
in triplicate. *p<0.05 determined by Mann Whitney U test compared to C. albicans-infected RHOE. 
^p<0.05 determined by Mann Whitney U test compared to uninfected RHOE. 
 
Figure 5. Human β-defensin 2 (HBD2) is upregulated in FTOM and EpiOral™ but not in 
RHOE upon C. albicans infection. Sections from uninfected and C. albicans-infected (5 x 
106CFU) FTOM, EpiOral™ and RHOE oral mucosal models were stained for hBD2 expression by 
immunohistochemistry. hBD2 expression (brown staining) was markedly increased in the FTOM 
and EpiOral™ models but not the RHOE models. Images are representative of models from three 
experiments each performed in triplicate. Scale bar = 100µM. 
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